Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. |
Relapsing Multiple Sclerosis | Phase3 | Argentina Australia Belgium Canada Denmark France Greece Italy Mexico Portugal Slovakia South Africa Spain Switzerland United Kingdom United States View all |
NCT06846281 |
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. |
Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis, Glomerular Disease, Glomerulonephritis, IGA, Glomerulopathy, Immunoglobulin Disease | Phase3 | Argentina South Korea United States |
NCT06858319 |
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN |
Glomerulonephritis, IGA, Immunoglobulin A Nephropathy | Phase2 | Argentina Israel Malaysia United States View all |
NCT06797518 |
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis |
Rheumatoid Arthritis | Phase1 | Argentina Bulgaria China Germany Netherlands Romania Spain View all |
NCT07029555 |
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis |
Atopic Dermatitis | Phase2 | Argentina Canada China Czechia France Germany Hungary Italy Japan Netherlands Poland Slovakia South Korea Spain Taiwan United Kingdom United States View all |
NCT06947993 |
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. |
Chagas Disease | Phase2 | Argentina Brazil Colombia United States View all |
NCT06632600 |
LATAM LOWERS LDL-C |
Hypercholesterolaemia | Phase4 | Argentina Brazil |
NCT06501443 |
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa |
Hidradenitis Suppurativa | Phase3 | Argentina Austria Belgium Canada Colombia Czechia France Germany Greece Hungary Malaysia Mexico Poland Puerto Rico Romania Spain Turkey (Türkiye) United Kingdom United States View all |
NCT06840392 |
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis |
Generalized Myasthenia Gravis | Phase3 | Argentina Australia Belgium Canada China France Georgia India Italy Japan Poland Romania South Korea Spain Taiwan United States View all |
NCT06744920 |
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) |
Hidradenitis Suppurativa | Phase3 | Argentina Australia Bulgaria Canada China Colombia Denmark Germany Greece Italy Malaysia Mexico Poland Portugal Slovakia South Africa Spain Switzerland Taiwan United States View all |
NCT06799000 |